Contraceptive Development Research Centers (P50 Clinical Trial Optional)
ID: 357196Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357196

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-26-004.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Contraceptive Development Research Centers (P50 Clinical Trial Optional)" aimed at advancing the development of new and improved contraceptive methods for both men and women. This initiative seeks to establish multidisciplinary Contraceptive Development Research Centers that will conduct laboratory and clinical research, including translational studies to enhance the likelihood of clinical success. The program is particularly focused on late-stage preclinical or clinical development of contraceptive products, encouraging proposals that explore innovative options such as non-steroidal contraceptives and novel delivery mechanisms. Up to $6 million in funding is available for fiscal year 2026, with a project period of up to four years. Interested applicants must submit their proposals by November 13, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HD-26-004-Full-Announcement.html
    RFA-HD-26-004.html
    The National Institutes of Health (NIH) under the Department of Health and Human Services is releasing a funding opportunity (RFA-HD-26-004) called the Contraceptive Development Research Centers (P50 Clinical Trial Optional). This initiative aims to bolster multidisciplinary efforts in developing new or improved contraceptive methods for men and women. It emphasizes establishing Contraceptive Development Research Centers to support both laboratory and clinical research while including translational studies for effective clinical outcomes. The NIH expects the Center to conduct at least two Contraception Development Research Projects focused on the late-stage preclinical or clinical development of contraceptive products, particularly those showing industrial interest. Applicants are encouraged to submit diverse proposals addressing areas like non-steroidal male and female contraceptives and innovative delivery mechanisms. Funding availability includes up to $6 million for FY 2026 with a project period extending to four years. Eligible organizations include higher education institutions, nonprofits, and government entities. The application deadline is November 13, 2025, with an important emphasis on conforming to the guidelines set forth in the application instructions. The focus on enhancing contraceptive options reflects a commitment to addressing public health needs through innovative research.
    Similar Opportunities
    Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for the development of novel or improved infertility technologies through a phased R61/R33 grant mechanism. This initiative aims to support multidisciplinary research focused on creating or enhancing technologies, including drugs, devices, and clinical practices, to improve fertility outcomes, particularly in the context of assisted reproductive technologies (ART). With an estimated total program funding of $3.3 million and the expectation of awarding 11 grants, potential applicants are encouraged to prepare collaborative projects in advance of the official solicitation, which is anticipated to be published in July 2025. For further inquiries, interested parties can contact Travis Kent, PhD, at travis.kent@mail.nih.gov or call 301-435-2295.
    Biological Testing Facility for Contraception & Reproductive Health
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for access to a state-of-the-art Biological Testing Facility (BTF) aimed at advancing contraceptive and reproductive health-related product development. This initiative seeks to support innovative and validated methods for fertility regulation and the development of new therapies in reproductive health, addressing a critical need for effective fertility regulation methods. While applications are not currently being solicited, potential applicants are encouraged to prepare their projects in anticipation of the opportunity, with an estimated synopsis post date of October 6, 2025, and an estimated award date of February 23, 2026. For further inquiries, interested parties can contact Dr. Leigh Allen at leigh.allen@nih.gov or by phone at 301-594-9151.
    Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Planning for Product Development Strategy," aimed at supporting the development of comprehensive strategies for next-generation treatments and preventive measures for HIV and its associated complications. This grant opportunity encourages eligible applicants, including various educational institutions and community organizations, to create innovative product development plans that align with FDA guidelines, facilitating the submission of Investigational New Drug (IND) applications. With a total estimated funding of $225,000 available for individual projects, applications are due by December 5, 2026, and must adhere to specific guidelines emphasizing scientific merit and compliance. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link provided in the announcement.
    Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) grant, aimed at establishing innovative nursing-led research centers that focus on community-partnered research to tackle persistent health challenges. Applicants are required to propose strategies that enhance research infrastructure within Schools or Colleges of Nursing, develop nurse-led interdisciplinary teams, and engage the community meaningfully throughout all research activities, including the execution of at least one pilot project that generates preliminary data for future NIH submissions. This initiative is critical for fostering sustainable research infrastructure and improving health outcomes in diverse communities. The grant offers a maximum funding amount of $500,000 per year for a project period of up to five years, with applications due by May 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-439.html.
    Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Planning for Product Development Strategy," aimed at supporting the development of comprehensive strategies for next-generation treatments and preventive methods for HIV and associated complications. The primary objective of this grant is to facilitate the planning activities necessary for submitting an Investigational New Drug (IND) application to the FDA, with a focus on translating innovative research into effective drug products. This funding opportunity is particularly significant as it encourages collaboration among multidisciplinary teams to address critical health challenges related to HIV. Interested applicants can apply starting February 13, 2024, with a total funding amount of $1,000,000 anticipated for 2-3 awards in fiscal year 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-029.html.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders. This funding opportunity supports integrated, multidisciplinary research programs that include 3-4 synergistic research projects and an administrative core, with the possibility of 1-2 optional scientific cores, all centered around a unifying clinical theme. The maximum project period is five years, with budgets capped at $1,500,000 in direct costs per year for new applications. Eligible applicants include various organizations, excluding foreign entities, and are encouraged to consult with NIDCD staff prior to submission to ensure responsiveness. The application deadline is June 2, 2028, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Funding Opportunity Announcement (FOA) aimed at improving the uptake and use of the dapivirine vaginal ring for HIV prevention. This initiative seeks to advance research on understanding the multilevel facilitators and barriers to the use of the vaginal ring, develop interventions to enhance its uptake and consistent use, and test implementation strategies for optimal delivery. The anticipated funding amount for this grant is up to $500,000, with the FOA expected to be published in Winter 2022 and applications due in Summer 2022. Interested applicants can reach out to Dr. Teri Senn at teri.senn@nih.gov or by phone at 301-761-7852 for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Intellectual and Developmental Disabilities Research Centers (IDDRCs) in 2025, with a focus on advancing research in the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD). This initiative aims to foster collaborative research through specialized centers supported by multi-project grant awards under the P50 activity code. The anticipated funding amount for each center is up to $1 million, with the NOFO expected to be published in Summer 2024 and applications due in Fall 2024. Interested applicants should prepare to develop meaningful collaborations and responsive projects, as the estimated award date is set for July 1, 2025.
    Diabetes Research Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Diabetes Research Centers (P30 Clinical Trial Optional) grant, aimed at enhancing national research efforts in diabetes and related diseases. This funding opportunity encourages collaboration among basic and clinical investigators by providing shared technical resources and a Pilot and Feasibility Program, with a focus on innovative approaches and synergies with other NIDDK-funded programs. Eligible applicants include various higher education institutions, nonprofits, and government entities, with a maximum funding amount of $1 million per year, and a total estimated program funding of $18.2 million for approximately seven awards. Interested parties should note that the application deadline is January 27, 2027, and can reach out to the Division of Diabetes, Endocrinology and Metabolic Diseases at NIDDKDEM@nih.gov for further information.
    Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R21 Exploratory/Developmental Research Grant under the funding opportunity titled "Innovations to Optimize HIV Prevention and Care Continuum Outcomes." This initiative aims to support innovative research that enhances HIV prevention and care strategies by exploring behavioral and social science approaches, new intervention methods, and implementation science, particularly addressing gaps in engagement, adherence, and retention in healthcare services. The grant, with a funding ceiling of $275,000 over two years, emphasizes collaboration with community organizations and the inclusion of diverse populations, aligning with national and global health objectives. Interested applicants can submit their proposals until January 9, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.